Moreover, in our previous study, we have conveyed that serum IGFBP7 has the potential of early diagnosis for esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma (Huang et al., 2019; Liu et al., 2020). This evidence concerns the gene IGFBP7 and esophageal squamous cell carcinoma.